Earth Science Tech Inc. (OTC: ETST) has evolved into a diversified healthcare holding company with operations spanning telemedicine, compounding pharmacies, clinical support services, and healthcare fulfillment. The company has also actively reduced its share count through a series of share repurchases documented in SEC filings and share structure records, distinguishing itself in the OTC market where share structure often receives as much attention as revenue growth or acquisition activity.
According to the company’s most recent Form 10-Q, covering the quarter ended December 31, 2025, Earth Science Tech repurchased 1,143,000 common shares during the quarter for approximately $647,000, as detailed in the filing available at https://ibn.fm/Gm12j. Over the nine months ended December 31, 2025, the company repurchased a total of 3.7 million shares. Management continues to emphasize shareholder value through balance-sheet management alongside acquisitions and operating growth.
For many investors evaluating companies on the OTC market, share structure is a critical factor. Earth Science Tech’s sustained program of share repurchases has reduced outstanding shares while the company simultaneously expands its healthcare-focused operating platform. This dual approach of aggressive buybacks and operational expansion positions the company to potentially enhance earnings per share and signal confidence in its future prospects.
The company is scheduled to present to investors at the Planet MicroCap Las Vegas 2026 conference in June, providing an opportunity to discuss its strategy and recent developments. The latest news and updates relating to ETST are available in the company’s newsroom at https://ibn.fm/ETST.
Earth Science Tech’s focus on reducing share count while expanding its healthcare operations may have implications for investors seeking companies with disciplined capital allocation strategies. The repurchase program could help support the stock price and increase ownership stakes for remaining shareholders. As the company continues to grow its telemedicine, pharmacy, clinical support, and fulfillment businesses, the reduced share count could amplify the impact of future earnings on per-share metrics.
This news matters because it highlights a microcap company actively managing its capital structure to potentially deliver shareholder value, a strategy that often resonates with value-oriented investors. The combination of operational expansion in the healthcare sector with financial discipline through share repurchases could set a precedent for other small-cap companies navigating the OTC market.
